| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-adrenoceptor density in pacing-induced heart failure
Cardiology Unit, Department of Medicine, Department of Neurobiology and Anatomy, University of Rochester Medical Center, Rochester, New York 14642
Congestive heart failure is associated with cardiac
adrenergic nerve terminal changes and 
-adrenoceptor density
downregulation. To study the temporal sequence of these changes, we
performed studies in rabbits at 2, 4, and 8 wk of cardiac pacing (360 beats/min) and at 1, 2, and 4 wk after cessation of pacing. Rapid
pacing produced left ventricular (LV) dysfunction and an increase in plasma norepinephrine (NE) in 1-2 wk. At week 2, NE uptake
activity, NE uptake-1 density, and adenylyl cyclase responses to
isoproterenol, 5'-guanylyl imidodiphosphate
[Gpp(NH)p], and forskolin reduced. However, immunostained
tyrosine hydroxylase profile, -adrenoceptor density, and NE
histofluorescence did not reduce until 4-8 wk of pacing. After
cessation of cardiac pacing, LV function normalized quickly, followed
by return of tyrosine hydroxylase and NE profiles in 1 wk and adenylyl
cyclase responses to agonists and NE uptake activity in 2 wk.
Myocardial -adrenoceptor density returned to normal by 4 wk after
cessation of pacing. Our results suggest that there is no permanent
structural neuronal damage in the myocardium within the first 8 wk of
rapid cardiac pacing. Abnormal myocardial NE reuptake mechanism may
play an important pathophysiological role in heart failure.
norepinephrine; norepinephrine reuptake; adrenergic nerve terminals; pacing-induced cardiomyopathy
This article has been cited by other articles:
|
|
 |
|
  G. H. Hankes, J. L. Ardell, J. Tallaj, C.-C. Wei, I. Aban, M. Holland, P. Rynders, R. Dillon, R. Cardinal, D. B. Hoover, et al. beta1-Adrenoceptor blockade mitigates excessive norepinephrine release into cardiac interstitium in mitral regurgitation in dog Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H147 - H151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-s. Liang, W. Mao, C. Iwai, S. Fukuoka, and S. Y. Stevens Cardiac sympathetic neuroprotective effect of desipramine in tachycardia-induced cardiomyopathy Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H995 - H1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts Hypertension, February 1, 2006; 47(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Munch, K. Rosport, A. Bultmann, C. Baumgartner, Z. Li, L. Laacke, and M. Ungerer Cardiac Overexpression of the Norepinephrine Transporter Uptake-1 Results in Marked Improvement of Heart Failure Circ. Res., October 28, 2005; 97(9): 928 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Mao, C. Iwai, F. Qin, and C.-s. Liang Norepinephrine induces endoplasmic reticulum stress and downregulation of norepinephrine transporter density in PC12 cells via oxidative stress Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2381 - H2389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kawai, F. Qin, J. Shite, W. Mao, S. Fukuoka, and C.-s. Liang Importance of antioxidant and antiapoptotic effects of {beta}-receptor blockers in heart failure therapy Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1003 - H1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Mao, F. Qin, C. Iwai, R. Vulapalli, P. C. Keng, and C.-s. Liang Extracellular norepinephrine reduces neuronal uptake of norepinephrine by oxidative stress in PC12 cells Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H29 - H39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-s. Liang Sympatholysis and cardiac sympathetic nerve function in the treatment of congestive heart failure J. Am. Coll. Cardiol., August 6, 2003; 42(3): 549 - 551. [Full Text] [PDF]
|
|
|
|
|
|
F. Qin, J. Shite, and C.-s. Liang Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H822 - H832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-s. Liang, A. Yatani, Y. Himura, M. Kashiki, and S. Y. Stevens Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1729 - H1736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Liang, Y. Himura, M. Kashiki, and S. Y. Stevens Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1863 - H1872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawai, S. Y. Stevens, and C.-S. Liang Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
